Catalyst Biosciences Inc - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for Catalyst Biosciences Inc are shown. This report of Catalyst Biosciences Inc uses data points from across the web and also from available documents by Catalyst Biosciences Inc. Complete Sustainability assessment of Catalyst Biosciences Inc are accessed by registering for free.
Catalyst Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 2.7, social score of 0.0 and governance score of 2.0.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Cerus Corp | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Catalyst Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Catalyst Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Catalyst Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Catalyst Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Catalyst Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Catalyst Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Catalyst Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Catalyst Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Catalyst Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Catalyst Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Catalyst Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Catalyst Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Catalyst Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Catalyst Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Catalyst Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Catalyst Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Catalyst Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Catalyst Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.